About
IR-MED Inc. is developing a cutting-edge infrared spectroscopy and AI analysis technology platform as a basis for point-of-care decision support devices. The infrared spectroscopy technology allows harmless and non-invasive gathering of bio-information from patient blood and tissue. Bioinformation is then analyzed using the company's AI process to provide healthcare professionals with decision support in assessment of various disease conditions. PressureSafe, the company's first product based on this platform, is a handheld device designed to revolutionize assessment of pressure injuries (PI) affecting skin and underlying tissue. Pressure Injury in the US alone accounts for $26.8B in healthcare spending and results in 60,000 deaths annually. PressureSafe is expected to contributes to assessment of pressure injuries before skin breakage , regardless of patient skin tone. This will drive equitable healthcare and help reduce the toll and cost of PI. IR-MED holds patents protecting its innovation in noninvasive tissue assessment.
Technologies
Keywords
Company Information
-
Employees 3
-
Founded 2012
-
Annual Revenue $26000
-
Total Funding $6406000
Location
יהלום, Rosh Pinna, North District, Israel, 12000
